- Commissioner Enhances FDA’s Commitment to Personalized Medicine
- Perfecting Policy on Stem Cells
- NIH and FDA Aim to Retool Regulatory Science
- DOE Leads Federal Funding for a Regional Innovation Cluster
- Certainty on the Science of Climate Change
- They’re Not Perfect Cells, But They’re Model Cells
- Genomic Medicine on the March
- President’s Budget Aims to Recharge Regional Innovation
- Event: The Science of Climate Change
- Progress in Bioethics
- The Top Science Progress Features of 2009
- Science Education Progress
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
Stem Cell News Roundup: Dec 3, 2007
“A new way to trick skin cells into acting like embryos changes both everything and nothing at all.” Alan I. Leshner and James A. Thomson on the new advances in stem cell research. Their Op-Ed was in response to Charles Krauthammer’s Friday column claiming that the recent discoveries by Thomson and Shinya Yamanaka were a vindication of President Bush’s moral stance on the issue.
The Daily Telegraph gets into detail about the genes used to reprogram skin cells into iPS cells and the potential risks involved.
Shinya Yamanaka led one of the teams behind the iPS breakthrough and published another paper in Nature Biotechnology detailing the transformation of mouse skin cells without using the cancer-causing gene c-Myc. Wired provides a thoughtful summary, Reuters does thorough reporting, and the LA Times gives it a brief mention.
The AFP covers another new stem cell discovery coming from Georgetown Medical School and the Washington Regional Transplant Community (WRTC) that turns primordial germinal cells (i.e.: precursors to spermatazoids) into colonies with characteristics similar to stem cells.
Wired reports that the California Institute for Regenerative Medicine will now be spending up to $13 million in 2008 on non-embryonic stem cell research. Also: CIRM’s recent auditing by the State Controller due to a conflict-of-interest issue.
The Guardian Weekly features an interview with bioethicist Darryl Macer about the ethics of cloning and embryonic research.
Comments on this article
